LONDON — A U.K. commission on Thursday unveiled its recommendations for how the country should regulate artificial intelligence in medicine, as health authorities globally try to determine how to continuously review ever-changing products after they have been authorized instead of simply clearing them once for the market. 

In its report, the commission sought to strike a balance between ensuring that the U.K. takes advantage of AI’s potential in medicine — the ability to review the millions of scans that are generated each year to track the eye health of patients with diabetes, for example — while prioritizing safety, tracking device performance over time, and treating patients equitably.

The 44 recommendations include some that would allow for the staged authorization of new AI models and others that would build a system for providers to report how tools are performing in their clinics — including when they malfunction or potentially inhibit patient care — as the models learn and adapt and perform differently depending on the setting.  

Continue to STAT+ to read the full story…

ARPA-H, the government agency that funds cutting-edge health research, plans to commit $62.7 million to develop artificial intelligence bots that direct treatment of heart failure. Among the goals of the program, called ADVOCATE, is to produce partially autonomous AI devices authorized by the Food and Drug Administration to help treat patients, including assessing symptom severity, prescribing drugs, and ordering lab tests. 

ARPA-H on Wednesday announced the first batch of awards to health tech companies Atman Health, UpDoc, Tempus AI, and teams from Stanford University, Duke University, and the Kaiser Permanente health system. ARPA-H may still fund additional teams. The amount committed for the first year is $33.7 million, and the remainder may be renegotiated up or down. 

Many of the 6.7 million Americans with heart failure don’t get optimal treatment because of difficulty accessing specialists, and the hope is that AI agents developed with ARPA-H funding can help address the gap, especially in rural and other underserved settings.

Continue to STAT+ to read the full story…

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. 

It’s hard to resist the world’s obsession with productivity and efficiency and to force yourself to be present in a quiet space. I’ve been enjoying the wandering_cassettes Instagram account, which posts videos of Fisher Price cassette players playing songs in different settings. This one is particularly calming, but they’re all timeline cleansers.

The newsletter will be off next week as I work on a big new story, but I’ll be back in your inboxes Sept. 23.

AI scribes only fix a tiny slice of the problem

Today’s AI Prognosis — and my new story — are brought to you by “The Pitt.” Not in any financial way — I just mean that I finally started watching “The Pitt.” (No spoilers! I’m only halfway through season two.)

Everyone is right — it is extremely compelling television. But what struck me the most was how “The Pitt” feels exactly like the ambulance ride-alongs and emergency department shadowing visits I’ve done: Dropping in on the worst day of someone’s life, but doing it over and over every 40 minutes, for eight to 12 hours, without enough resources.

Continue to STAT+ to read the full story…

Ezekiel J. Emanuel and Abe Baker-Butler have been debating the proper place for AI in medicine with American Medical Association CEO John Whyte. Now, they are taking their discussion to STAT’s First Opinion. Read Emanuel and Baker-Butler’s essay below and read Whyte’s essay here.

In 1867, Joseph Lister published his research on carbolic acid and antiseptic surgical technique.  In September 1871, he was summoned to Queen Victoria, who had a rapidly growing abscess in her left armpit. Using his antiseptic surgical technique, Joseph Lister successfully drained the pus. Queen Victoria recovered without fever or other complications. The antiseptic technique quickly gained approval in the U.K. and Europe, but not among American physicians.  

Read the rest…

Ezekiel J. Emanuel and Abe Baker-Butler have been debating the proper place for AI in medicine with American Medical Association CEO John Whyte. Now, they are taking their discussion to STAT’s First Opinion. Read Whyte’s essay below and read Emanuel and Baker-Butler‘s essay here.

Would you want artificial intelligence to tell you that you have cancer?

Read the rest…

BOSTON — The building that houses the Brigham and Women’s Hospital emergency department opened in 2022. But by 2025, it was already too small. One early September evening, the emergency room had 59 patients — 152, if you counted everyone in the waiting room. 

“In terms of rooms for acute care, we have 61,” said Christopher Baugh, an emergency physician at the hospital. “You can’t see 152 patients in 61 rooms.” Patient beds lined every possible area, with a full circle of beds surrounding the staff workstations in the center of the bay. Figurines of Star Wars characters R2D2 and C3PO peered over beds 80H and 81H — where “H” stands for “hallway.”

To some, this may look like a scene from another country, Baugh said. But to him, it’s just Thursday.

Continue to STAT+ to read the full story…

Good morning health tech readers!

I hope you had a wonderful long weekend.

Reach me: mario.aguilar@statnews.com

Continue to STAT+ to read the full story…